Institutional Ownership
Denali Therapeutics Inc
CUSIP 24823R105COMDNLIQ1 2026
13D / 13G Filings
51
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
21.3%
Max % of class reported
Institutional Holders
260
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
51 filings · latest Nov 5, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 5, 2025 | Fmr LLC | 13G/A | 5.8% | 8.54M | SEC |
| 2 | Aug 12, 2025 | Wellington Management Group LLP | 13G/A | 3.9% | 5.66M | SEC |
| 3 | Aug 8, 2025 | Baillie Gifford &Amp; Co | 13G | 5.6% | 2.20M | SEC |
| 4 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.2% | 10.49M | SEC |
| 5 | Feb 13, 2025 | Capital Research Global Investors | 13G/A | 3.8% | 5.48M | SEC |
| 6 | Feb 12, 2025 | Baillie Gifford &Amp; Co | 13G/A | 7.2% | 2.74M | SEC |
| 7 | Feb 12, 2025 | Baillie Gifford &Amp; Co | 13G/A | 8.6% | 12.31M | SEC |
| 8 | Nov 12, 2024 | Capital Research Global Investors | 13G | 5.5% | 7.91M | SEC |
| 9 | Nov 12, 2024 | Fmr LLC | 13G/A | 7.1% | — | SEC |
| 10 | Nov 8, 2024 | Blackrock, Inc. | 13G/A | 9.6% | 13.79M | SEC |
41 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Denali Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 13.03M | $250.26M |
| 2 | Baillie Gifford & Co | 12.07M | $231.68M |
| 3 | Temasek Holdings (Private) Ltd | 7.01M | $134.65M |
| 4 | State Street Corp | 6.27M | $120.42M |
| 5 | Fmr LLC | 4.58M | $87.85M |
| 6 | Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LLC | 4.43M | $85.10M |
| 7 | Goldman Sachs Group Inc | 4.41M | $84.62M |
| 8 | Baker Bros. Advisors LP | 3.73M | $71.65M |
| 9 | Geode Capital Management, LLC | 3.73M | $71.58M |
| 10 | Holocene Advisors, LP | 3.20M | $61.35M |